Last reviewed · How we verify

NCT04278066: HYPER-CARDIO

Hyperoxia and Pulmonary Complications After Cardiac Surgery

Completed Last updated 7 October 2021
What this trial tests

trial in Hyperoxia in 300 participants. Completed in 5 September 2020.

Timeline
5 February 2020
Primary endpoint
5 September 2020
5 September 2020

Quick facts

Lead sponsorUniversity Hospital, Strasbourg, France
StatusCompleted
Study typeOBSERVATIONAL
Enrollment300
Start date5 February 2020
Primary completion5 September 2020
Estimated completion5 September 2020
Sites1 location across France

Conditions studied

Sponsor

University Hospital, Strasbourg, France

Who can join

18 and older, any sex, with Hyperoxia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main objective is to demonstrate that hyperoxia in cardiac surgery increase the occurrence of post-operative pulmonary complications

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Hyperoxia

Currently open trials in the same condition.

Other University Hospital, Strasbourg, France trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04278066.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing